Esther Voigt
University of Oxford(GB)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, HIV Research and Treatment, Immune Cell Function and Interaction, Hepatitis B Virus Studies
Most-Cited Works
- Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.(2005)
- → Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients(2004)97 cited
- → An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients(2014)55 cited
- → Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: Outcome of 7 patients from the Bonn cohort(2005)41 cited
- → Phage strategies facilitate bacterial coexistence under environmental variability(2021)41 cited
- → Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients(2005)39 cited
- → First‐line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48‐week results(2002)33 cited
- → Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort(2007)26 cited
- → Safety, Efficacy and Development of Resistance under the New Protease Inhibitor Lopinavir/Ritonavir: 48-Week Results(2004)20 cited
- → CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C(2015)20 cited